180 related articles for article (PubMed ID: 11074064)
1. Relationship of plasma bone cytokines with hypercalcemia in cancer patients.
Motellón JL; Jiménez FJ; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
Clin Chim Acta; 2000 Dec; 302(1-2):59-68. PubMed ID: 11074064
[TBL] [Abstract][Full Text] [Related]
2. Elevation of circulating plasma cytokines in cancer patients with high plasma parathyroid hormone-related protein levels.
Takahashi S; Hakuta M; Aiba K; Ito Y; Horikoshi N; Miura M; Hatake K; Ogata E
Endocr Relat Cancer; 2003 Sep; 10(3):403-7. PubMed ID: 14503917
[TBL] [Abstract][Full Text] [Related]
3. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
Tanaka K; Shiraishi K; Sakamoto A; Jojima H; Masuchi K; Okubo Y; Tanaka M; Fuzimatsu Y; Fukahori S; Osabe S; Imamura Y; Honda J; Oizumi K
Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894
[TBL] [Abstract][Full Text] [Related]
4. Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma.
Abildgaard N; Glerup H; Rungby J; Bendix-Hansen K; Kassem M; Brixen K; Heickendorff L; Nielsen JL; Eriksen EF
Eur J Haematol; 2000 Feb; 64(2):121-9. PubMed ID: 10997332
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum levels of interleukin-6, tumor necrosis factor-alpha and bone turnover markers in prostate cancer patients.
Akimoto S; Okumura A; Fuse H
Endocr J; 1998 Apr; 45(2):183-9. PubMed ID: 9700471
[TBL] [Abstract][Full Text] [Related]
6. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
Guise TA; Yoneda T; Yates AJ; Mundy GR
J Clin Endocrinol Metab; 1993 Jul; 77(1):40-5. PubMed ID: 8325957
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
8. Hypercalcemia of malignancy--new insights into an old syndrome.
Esbrit P
Clin Lab; 2001; 47(1-2):67-71. PubMed ID: 11214225
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone-related protein, parathyroid hormone, and vitamin D in hypercalcemia of malignancy.
Motellón JL; Javort Jiménez F; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
Clin Chim Acta; 2000 Jan; 290(2):189-97. PubMed ID: 10660809
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by human interleukin-1 alpha of parathyroid hormone-related peptide effects on renal calcium and phosphorus metabolism in the rat.
Tørring O; Turner RT; Carter WB; Firek AF; Jacobs CA; Heath H
Endocrinology; 1992 Jul; 131(1):5-13. PubMed ID: 1319327
[TBL] [Abstract][Full Text] [Related]
12. Hypercalcemia in a patient with B-cell acute lymphoblastic leukemia: a role of proinflammatory cytokine.
Fukasawa H; Kato A; Fujigaki Y; Yonemura K; Furuya R; Hishida A
Am J Med Sci; 2001 Aug; 322(2):109-12. PubMed ID: 11523624
[TBL] [Abstract][Full Text] [Related]
13. Severe hypercalcemia in a child with acute nonlymphocytic leukemia: the role of parathyroid hormone-related protein and proinflammatory cytokines.
Kounami S; Yoshiyama M; Nakayama K; Hiramatsu C; Aoyagi N; Yoshikawa N
Acta Haematol; 2004; 112(3):160-3. PubMed ID: 15345899
[TBL] [Abstract][Full Text] [Related]
14. Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD.
Zeng YY; Hu WP; Zuo YH; Wang XR; Zhang J
Int J Chron Obstruct Pulmon Dis; 2019; 14():163-168. PubMed ID: 30655663
[TBL] [Abstract][Full Text] [Related]
15. Dependence of humoral hypercalcemia of malignancy on parathyroid hormone-related protein expression in the canine anal sac apocrine gland adenocarcinoma (CAC-8) nude mouse model.
Gröne A; Weckmann MT; Blomme EA; Capen CC; Rosol TJ
Vet Pathol; 1998 Sep; 35(5):344-51. PubMed ID: 9754539
[TBL] [Abstract][Full Text] [Related]
16. Bone remodelling markers and serum cytokines in patients with hyperthyroidism.
Akalin A; Colak O; Alatas O; Efe B
Clin Endocrinol (Oxf); 2002 Jul; 57(1):125-9. PubMed ID: 12100080
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer.
Grill V; Ho P; Body JJ; Johanson N; Lee SC; Kukreja SC; Moseley JM; Martin TJ
J Clin Endocrinol Metab; 1991 Dec; 73(6):1309-15. PubMed ID: 1955513
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer.
Akimoto S; Akakura K; Shimazaki J
Jpn J Clin Oncol; 1996 Jun; 26(3):157-63. PubMed ID: 8656556
[TBL] [Abstract][Full Text] [Related]
19. Type I collagen and procollagen fragments in patients with metabolic bone diseases.
Lin JS; Kao JT; Tsai KS
J Formos Med Assoc; 1996 Jul; 95(7):523-9. PubMed ID: 8840753
[TBL] [Abstract][Full Text] [Related]
20. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
Burtis WJ; Brady TG; Orloff JJ; Ersbak JB; Warrell RP; Olson BR; Wu TL; Mitnick ME; Broadus AE; Stewart AF
N Engl J Med; 1990 Apr; 322(16):1106-12. PubMed ID: 2320080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]